About

Dr. Bernadette Awankem

I combine three perspectives that rarely come together in one person: research, field sales and Medical Affairs.

Career

• Since 2025: Independent Medical Affairs consultant (BoMedAC®)
• 2022–2025: Medical Science Liaison Manager, Norgine Pharma GmbH – gastroenterology, hepatology, iron deficiency, induction of labour, malignant hyperthermia
• 2021–2022: Key Account Manager, Tillotts Pharma GmbH – IBD, C. difficile infection
• 2010–2019: Pharmaceutical representative via MARVECS, Quintiles and Careforce for Bayer Vital, Novo Nordisk, Boehringer Ingelheim, Pfizer, Urgo and Coloplast – diabetes, anticoagulation, respiratory, vaccines, chronic wounds
• 2003–2009: Research at the university hospitals of Giessen, Magdeburg and Münster, and at Merck KGaA (toxicology)

Qualifications

• PhD (Dr. rer. nat., magna cum laude), University of Giessen, 2006
• Diploma (MSc) in Biochemistry, Freie Universität Berlin, 2003
• Certified Clinical Research Associate, Pharmaakademie Leipzig, 2020
• Modular Medical Advisor qualification, 2024
• Certificate in patent law, Beuth University Berlin
• Life Science Management, ATV Munich
• Epidemiology: Imperial College London and Johns Hopkins University (Coursera)
• MDR 2017/745 course, 2023

The team

For projects that need more than one person, BoMedAC® works with a fixed core team. Team members are not named publicly; we introduce their profiles as part of a specific proposal.

• Medical Affairs (lead): Dr. Bernadette Awankem
• Clinical monitoring: Clinical Monitoring Specialist – study support and monitoring of clinical trials
• Preclinical and medical writing: Preclinical Research Manager and Medical Writer – preclinical projects, scientific writing and publications

Engagement

Founder of Pan African Health Systems Network e. V.; GIZ laureate in 2022 (community health entrepreneurship) and 2025 (agropreneurship). Co-author of a BMJ article on sex and gender in medical innovation (2023).

LinkedIn profile · drawankem@bomedac.com